Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (34)

2024

  1. Cytomegalovirus UL44 protein induces a potent T-cell immune response in mice

    Antiviral Research, Vol. 227

  2. Donor-Dependent Variations in Systemic Oxidative Stress and Their Association with One-Year Graft Outcomes in Kidney Transplantation

    American journal of nephrology, Vol. 55, Núm. 5, pp. 509-519

  3. Natural history and prognostic factors of candidemia in kidney transplant recipients: A retrospective, multinational study

    Mycoses, Vol. 67, Núm. 1

  4. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment

    Journal of Global Antimicrobial Resistance, Vol. 29, pp. 215-221

  2. Effect of Combination Antibiotic Empirical Therapy on Mortality in Neutropenic Cancer Patients with Pseudomonas aeruginosa Pneumonia

    Microorganisms, Vol. 10, Núm. 4

  3. Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 5, pp. 1452-1460

  4. Non-Tuberculous Mycobacteria and Aspergillus Lung Co-Infection: Systematic Review

    Journal of Clinical Medicine, Vol. 11, Núm. 19

  5. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  6. Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events

    Atherosclerosis Plus, Vol. 48, pp. 37-46

2021

  1. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

    Transplant infectious disease : an official journal of the Transplantation Society, Vol. 23, Núm. 3, pp. e13520

  2. IL-6–based mortality prediction model for COVID-19: Validation and update in multicenter and second wave cohorts

    Journal of Allergy and Clinical Immunology, Vol. 147, Núm. 5, pp. 1652-1661.e1

  3. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

    Mycoses, Vol. 64, Núm. 11, pp. 1334-1345

  4. Invasive fusariosis in nonneutropenic patients, Spain, 2000-2015

    Emerging Infectious Diseases, Vol. 27, Núm. 1, pp. 26-35

  5. Longitudinal dynamics of SARS-CoV-2-specific cellular and humoral immunity after natural infection or BNT162b2 vaccination

    PLoS Pathogens, Vol. 17, Núm. 12

2020

  1. A critical review of the relationship between post-transplant atherosclerotic events and cytomegalovirus exposure in kidney transplant recipients

    Expert Review of Anti-Infective Therapy, Vol. 18, Núm. 2, pp. 113-125

  2. Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa

    Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4

  3. Direct T-cell Inhibition and Agents Targeting T-cell Migration and Chemotaxis

    Infectious Disease Clinics of North America, Vol. 34, Núm. 2, pp. 191-210

  4. Predictive tools to determine risk of infection in kidney transplant recipients

    Expert Review of Anti-Infective Therapy, Vol. 18, Núm. 5, pp. 423-441